PT1280527E - Utilizacao de derivados de acriloil distamicina no tratamento de tumores associados a niveis de glutationa elevados - Google Patents

Utilizacao de derivados de acriloil distamicina no tratamento de tumores associados a niveis de glutationa elevados

Info

Publication number
PT1280527E
PT1280527E PT01933856T PT01933856T PT1280527E PT 1280527 E PT1280527 E PT 1280527E PT 01933856 T PT01933856 T PT 01933856T PT 01933856 T PT01933856 T PT 01933856T PT 1280527 E PT1280527 E PT 1280527E
Authority
PT
Portugal
Prior art keywords
treatment
sub
derivatives
glutationa
distamicine
Prior art date
Application number
PT01933856T
Other languages
English (en)
Inventor
Paolo Cozzi
Italo Beria
Geroni Maria Cristina Rosa
Original Assignee
Pharmacia Italia Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Italia Spa filed Critical Pharmacia Italia Spa
Publication of PT1280527E publication Critical patent/PT1280527E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/4155—1,2-Diazoles non condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyrrole Compounds (AREA)
PT01933856T 2000-05-08 2001-04-19 Utilizacao de derivados de acriloil distamicina no tratamento de tumores associados a niveis de glutationa elevados PT1280527E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0011059.3A GB0011059D0 (en) 2000-05-08 2000-05-08 Use of substituted acryloyl distamycin derivatives in the treatment of tumours associated with high levels of glutathione

Publications (1)

Publication Number Publication Date
PT1280527E true PT1280527E (pt) 2005-10-31

Family

ID=9891173

Family Applications (1)

Application Number Title Priority Date Filing Date
PT01933856T PT1280527E (pt) 2000-05-08 2001-04-19 Utilizacao de derivados de acriloil distamicina no tratamento de tumores associados a niveis de glutationa elevados

Country Status (29)

Country Link
US (1) US7030089B2 (pt)
EP (1) EP1280527B1 (pt)
JP (1) JP2003532669A (pt)
KR (1) KR100776184B1 (pt)
CN (1) CN1258362C (pt)
AR (1) AR029518A1 (pt)
AT (1) ATE300944T1 (pt)
AU (2) AU2001260227B2 (pt)
BR (1) BR0110628A (pt)
CA (1) CA2409664C (pt)
CZ (1) CZ300791B6 (pt)
DE (1) DE60112423T2 (pt)
DK (1) DK1280527T3 (pt)
EA (1) EA007506B1 (pt)
EE (1) EE200200605A (pt)
ES (1) ES2244618T3 (pt)
GB (1) GB0011059D0 (pt)
HK (1) HK1054193B (pt)
HU (1) HUP0301882A2 (pt)
IL (2) IL152388A0 (pt)
MX (1) MXPA02010962A (pt)
NO (1) NO20025303D0 (pt)
NZ (1) NZ522234A (pt)
PL (1) PL201289B1 (pt)
PT (1) PT1280527E (pt)
SK (1) SK286501B6 (pt)
TW (1) TWI284643B (pt)
WO (1) WO2001085144A2 (pt)
ZA (1) ZA200208531B (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0011059D0 (en) 2000-05-08 2000-06-28 Pharmacia & Upjohn Spa Use of substituted acryloyl distamycin derivatives in the treatment of tumours associated with high levels of glutathione
GB0015446D0 (en) 2000-06-23 2000-08-16 Pharmacia & Upjohn Spa Combined therapy against tumors comprising substituted acryloyl distamycin derivates,taxanes and/or antimetabolites
GB0015447D0 (en) 2000-06-23 2000-08-16 Pharmacia & Upjohn Spa Combined therapy against tumors comprising substituted acryloyl derivates and alkylating agents
GB0016447D0 (en) 2000-07-04 2000-08-23 Pharmacia & Upjohn Spa Process for preparing distamycin derivatives
IT1318696B1 (it) * 2000-09-15 2003-08-27 Pharmacia & Upjohn Spa Coniugati di glutatione con derivati della distamicina ad attivita'antitumorale.
US6969592B2 (en) 2001-09-26 2005-11-29 Pharmacia Italia S.P.A. Method for predicting the sensitivity to chemotherapy
DE60318561T2 (de) * 2002-04-02 2009-01-08 Nerviano Medical Sciences S.R.L., Nerviano Kombinierte tumortherapie auf der basis von distamycin-acryloyl derivaten und radiotherapie
DK3362056T3 (da) * 2015-10-15 2021-03-29 Advanced Biodesign Aminothiolesterforbindelser eller farmaceutisk acceptable salte deraf, til anvendelse ved behandling af cancer

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE468642B (sv) 1985-07-16 1993-02-22 Erba Farmitalia Poly-4-aminopyrrol-2-karboxamidoderivat och foerfarande foer deras framstaellning och en farmaceutisk komposition
GB8612218D0 (en) 1986-05-20 1986-06-25 Erba Farmitalia Site specific alkylating agents
DE3768419D1 (de) 1986-10-07 1991-04-11 Boehringer Biochemia Srl Pharmazeutische zusammensetzungen mit antineoplastischer wirkung.
GB8906709D0 (en) * 1989-03-23 1989-05-10 Creighton Andrew M Acryloyl substituted pyrrole derivatives
JP2919867B2 (ja) 1989-09-27 1999-07-19 千寿製薬株式会社 抗腫瘍剤
IT1272234B (it) * 1994-05-02 1997-06-16 Consiglio Nazionale Ricerche Derivati glutationici delle antracicline e procedimento per ottenerli.
GB9416005D0 (en) * 1994-08-08 1994-09-28 Erba Carlo Spa Peptidic compounds analogous to distamycin a and process for their preparation
US5880097A (en) * 1996-01-04 1999-03-09 Terrapin Techologies, Inc. Tethered prodrugs
AU1596097A (en) 1996-02-02 1997-08-22 Pharmacia & Upjohn S.P.A. Distamycin derivatives, process for preparing them, and their use as antitumor and antiviral agents
GB9610079D0 (en) 1996-05-14 1996-07-17 Pharmacia Spa Distamycin deriratives process for preparing them and their use as antitumor and antiviral agents
GB9615692D0 (en) * 1996-07-25 1996-09-04 Pharmacia Spa Acryloyl substituted distamycin derivatives, process for preparing them, and their use as antitumor and antiviral agents
GB9623522D0 (en) * 1996-11-11 1997-01-08 Pharmacia & Upjohn Spa Benzoheterocycle distamycin derivatives process for preparing them and their use as antitumour and antiviral agents
GB9727524D0 (en) 1997-12-31 1998-02-25 Pharmacia & Upjohn Spa Synergistic antitumor composition containing a biologically active ureido compound
GB9806692D0 (en) * 1998-03-27 1998-05-27 Pharmacia & Upjohn Spa Benzoheterocyclic distamycin derivatives, process for preparing them and their use as antitumour agents
GB9806689D0 (en) 1998-03-27 1998-05-27 Pharmacia & Upjohn Spa Acryloyl derivatives analogous to distamycin,process for preparing them,and their use as antitumour and antiviral agents
GB9816652D0 (en) 1998-07-30 1998-09-30 Pharmacia & Upjohn Spa Sulfurated distamycin derivatives process for preparing them and their use as antitumor agents
GB9816653D0 (en) 1998-07-30 1998-09-30 Pharmacia & Upjohn Spa Oxidised sulfurated distamycin derivatives process for preparing them and their use as antitumor agents
GB9928703D0 (en) * 1999-12-03 2000-02-02 Pharmacia & Upjohn Spa Acryloyl peptidic derivatives,process for their preparation and their use as antitumour agents
GB0011059D0 (en) 2000-05-08 2000-06-28 Pharmacia & Upjohn Spa Use of substituted acryloyl distamycin derivatives in the treatment of tumours associated with high levels of glutathione

Also Published As

Publication number Publication date
BR0110628A (pt) 2003-03-18
NO20025303L (no) 2002-11-05
TWI284643B (en) 2007-08-01
CZ300791B6 (cs) 2009-08-12
WO2001085144A2 (en) 2001-11-15
EP1280527A2 (en) 2003-02-05
MXPA02010962A (es) 2003-03-27
KR100776184B1 (ko) 2007-11-16
CN1427719A (zh) 2003-07-02
IL152388A (en) 2008-04-13
SK16002002A3 (sk) 2003-04-01
PL365831A1 (en) 2005-01-10
HK1054193A1 (en) 2003-11-21
PL201289B1 (pl) 2009-03-31
AU2001260227B2 (en) 2005-10-27
WO2001085144A3 (en) 2002-05-16
CN1258362C (zh) 2006-06-07
ZA200208531B (en) 2003-10-22
HK1054193B (zh) 2007-02-02
EA200201184A1 (ru) 2003-04-24
SK286501B6 (sk) 2008-11-06
EE200200605A (et) 2004-04-15
KR20030019371A (ko) 2003-03-06
EA007506B1 (ru) 2006-10-27
AR029518A1 (es) 2003-07-02
DE60112423D1 (de) 2005-09-08
US7030089B2 (en) 2006-04-18
JP2003532669A (ja) 2003-11-05
NO20025303D0 (no) 2002-11-05
ES2244618T3 (es) 2005-12-16
NZ522234A (en) 2004-09-24
CA2409664A1 (en) 2001-11-15
EP1280527B1 (en) 2005-08-03
HUP0301882A2 (hu) 2003-09-29
AU6022701A (en) 2001-11-20
CA2409664C (en) 2010-01-12
US20030207794A1 (en) 2003-11-06
CZ20023629A3 (cs) 2003-03-12
IL152388A0 (en) 2003-05-29
ATE300944T1 (de) 2005-08-15
DE60112423T2 (de) 2006-05-24
DK1280527T3 (da) 2005-10-17
GB0011059D0 (en) 2000-06-28

Similar Documents

Publication Publication Date Title
JO2503B1 (en) Benzathiazole derivatives
ATE360630T1 (de) Azabicyclische heterocyclen als modulatoren des cannabinoidrezeptors
BG66085B1 (bg) Фенилаланинови производни
TR200200579T2 (tr) Amino-tirazolpiridin türevleri.
ATE384058T1 (de) Thiazolderivate
BRPI0408858A (pt) uso de um inibidor de ibat ou, um sal, solvato, solvato de um tal sal ou uma pró-droga destes, farmaceuticamente aceitáveis, composição farmacêutica, e, método de tratamento e/ou profilaxia de constipação em um animal de sangue quente
IS6565A (is) Trópan afleiður nytsamlegar í meðferð
TR200201505T2 (tr) Terapötik maddeler olarak pirazolopirimidinler
MA27809A1 (fr) Amides d'acide pyrrolopyridine-2-carboxylique inhibiteurs de glycogene-phosphorylase
GB0225475D0 (en) Therapeutic agents
ATE401314T1 (de) Benzodiazepin-derivate als gamma-secretase inhibitoren
DE602004006166D1 (de) Azabicyclische heterocyclen als modulatoren des cannabinoidrezeptors
TR200101120T2 (tr) Serin proteaz inhibitörü
DE60045508D1 (de) Dalda-analoge und ihre verwendung
DE60121461D1 (de) Kondensierte pyridoindolderivate
BRPI0409959A (pt) uso de derivados de azetidinacarboxamida em terapia
TR200002466T2 (tr) Azetidin ve pirolidin türevleri
PT1280527E (pt) Utilizacao de derivados de acriloil distamicina no tratamento de tumores associados a niveis de glutationa elevados
AU8186701A (en) Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and alkylating agents
DK1102594T3 (da) Anvendelse af natriumchlorid til nedsættelse af den gastrointestinale toxicitet af derivater af camptothecin
MXPA03003971A (es) Derivados de indol como inhibidores de pde5.
ATE330958T1 (de) Pyrazino 1'2':1,6öpyrido 3,4-böindolderivate
NO20054086L (no) Depigmenteringsmidler